DENTSPLY SIRONA Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the Annual Meeting of Stockholders held on June 2, 2026. The filing covers the election of directors, ratification of auditors, executive compensation advisory vote, and an amendment to the company's incentive plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
- Director Elections: All 12 director nominees were elected. However, two nominees received significant "Against" votes:
- Donald J. Zurbay: 51,059,271 votes against (approx. 30.5% of votes cast).
- Betsy D. Holden: 23,407,281 votes against (approx. 14.1% of votes cast).
- Auditor Ratification: Deloitte and Touche LLP was ratified as the independent registered public accountant for 2026 with 182,033,381 votes for and 465,064 against.
- Executive Compensation: The non-binding advisory vote for 2025 executive compensation passed with 158,496,058 votes for and 9,090,084 against.
- Incentive Plan Amendment: Shareholders approved Amendment No. 2 to the 2024 Omnibus Incentive Plan to increase the share pool by 15,000,000 shares. The vote was 139,933,388 for and 27,713,777 against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, or specific risk factors. The document is limited to the disclosure of voting results.
Investor Verification Checklist
- Verify the reasons behind the significant "Against" votes for directors Donald J. Zurbay and Betsy D. Holden.
- Review the specific terms of Amendment No. 2 to the 2024 Omnibus Incentive Plan to understand the dilution impact of the 15,000,000 additional shares.
- Confirm the total number of shares outstanding to calculate the precise percentage of dissenting votes for the incentive plan amendment.